SCHEMBL6505505

SCHEMBL6505505

CCN(Cc1cncc(-c2ccc3c(c2)c(-c2ncc(C(=O)N[C@@H]4CCc5ccccc54)[nH]2)nn3C2CCCCO2)c1C)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.38
HPGD P15428 7/20 0.38
KDM4E B2RXH2 6/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
CYP2D6 P10635 3/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C19 P33261 2/20 0.36
HTT P42858 3/20 0.34
LMNA P02545 4/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
THRB P10828 1/20 0.34
MMP14 P50281 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CYP1A2 P05177 2/20 0.33
PKM P14618 1/20 0.33
CYP2C9 P11712 1/20 0.33
PDE2A O00408 1/20 0.32
POLB P06746 1/20 0.32
TAS1R3 Q7RTX0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6505088 1.00 ALDH1A1 (0.38) ALDH1A1HPGDKDM4EMEN1KMT2A
SCHEMBL6508245 0.89 RAB9A (0.35) ALDH1A1HPGDKDM4EMEN1KMT2A
SCHEMBL6508214 0.88 ATR (0.34)
SCHEMBL6505523 0.88 ALDH1A1 (0.35) ALDH1A1HPGDKDM4EMEN1KMT2A
SCHEMBL6505103 0.88 ALDH1A1 (0.35) ALDH1A1HPGDKDM4EMEN1KMT2A
SCHEMBL6510723 0.88 CNR2 (0.31)
SCHEMBL6508925 0.87 RXRA (0.32) DGAT2
SCHEMBL6505126 0.87 RXRA (0.30)
SCHEMBL6508778 0.86 CYP4F2 (0.33)
SCHEMBL6510591 0.86 PPARG (0.33) ALDH1A1HPGDKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050090529-A1 3,5 Disubstituted indazole compounds with nitrogen-bearing 5-membered heterocycles, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation PFIZER INC 2005-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090529-A1 3,5 Disubstituted indazole compounds with nitrogen-bearing 5-membered heterocycles, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation CDK3, CDK4, CDK9 ALDH1A1 3447/4885HPGD 811/4885KDM4E 846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.